Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

The nature of Asian biopharmaceutical innovation

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Jelinek, M. et al. Res. Technol. Manag. 55, 16–6 (2012).

    Article  Google Scholar 

  2. Code of Federal Regulations, Title 21 C.F.R. § 314.53.

  3. Friedman, Y. Nat. Rev. Drug Discov. 9, 835–836 (2010).

    Article  CAS  Google Scholar 

  4. Light, D.W. Health Aff. 28, w969–w977 (2009).

    Article  Google Scholar 

  5. Pharmaceutical Research and Manufacturers of America, Pharmaceutical Industry Profile 2012. http://www.phrma.org/sites/default/files/159/phrma_industry_profile.pdf (PhRMA; Washington, DC, April 2012)

  6. Locke, R.M. & Wellhausen, R. A Preview of the MIT Production in the Innovation Economy Report. http://web.mit.edu/pie/news/PIE_Preview.pdf (Massachusetts Institute of Technology, Cambridge, MA, 2013).

    Google Scholar 

  7. Breznitz, D. & Murphree, M. Run of the Red Queen Government, Innovation, Globalization, and Economic Growth in China (Yale University Press, New Haven CT, 2011)

    Google Scholar 

  8. National Science Board. Science and Engineering Indicators 2012. NSB 12–01 (National Science Foundation, Washington, DC, 2012)

  9. World Intellectual Property Organization. 2012 World Intellectual Property Indicators (WIPO, Geneva, Switzerland, December 2012)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yali Friedman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Friedman, Y. The nature of Asian biopharmaceutical innovation. Nat Biotechnol 32, 523–524 (2014). https://doi.org/10.1038/nbt.2933

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2933

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing